These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31464058)

  • 1. Associations between circulating inflammatory markers, diabetes type and complications in youth.
    Aulich J; Cho YH; Januszewski AS; Craig ME; Selvadurai H; Wiegand S; Jenkins AJ; Donaghue KC
    Pediatr Diabetes; 2019 Dec; 20(8):1118-1127. PubMed ID: 31464058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating markers of inflammation and endothelial function, and their relationship to diabetic retinopathy.
    Sasongko MB; Wong TY; Jenkins AJ; Nguyen TT; Shaw JE; Wang JJ
    Diabet Med; 2015 May; 32(5):686-91. PubMed ID: 25407692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between inflammation-related biomarkers and depressive symptoms in individuals with recently diagnosed type 1 and type 2 diabetes.
    Herder C; Fürstos JF; Nowotny B; Begun A; Strassburger K; Müssig K; Szendroedi J; Icks A; Roden M;
    Brain Behav Immun; 2017 Mar; 61():137-145. PubMed ID: 28041985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis.
    Hammana I; Malet A; Costa M; Brochiero E; Berthiaume Y; Potvin S; Chiasson JL; Coderre L; Rabasa-Lhoret R
    Diabetes Metab; 2007 Jun; 33(3):213-9. PubMed ID: 17418606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory markers are increased in youth with type 1 diabetes: the SEARCH Case-Control study.
    Snell-Bergeon JK; West NA; Mayer-Davis EJ; Liese AD; Marcovina SM; D'Agostino RB; Hamman RF; Dabelea D
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2868-76. PubMed ID: 20371668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory markers are associated with cardiac autonomic dysfunction in recent-onset type 2 diabetes.
    Herder C; Schamarek I; Nowotny B; Carstensen-Kirberg M; Straßburger K; Nowotny P; Kannenberg JM; Strom A; Püttgen S; Müssig K; Szendroedi J; Roden M; Ziegler D;
    Heart; 2017 Jan; 103(1):63-70. PubMed ID: 27481890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microvascular complications in patients with cystic fibrosis-related diabetes (CFRD).
    van den Berg JM; Morton AM; Kok SW; Pijl H; Conway SP; Heijerman HG
    J Cyst Fibros; 2008 Nov; 7(6):515-9. PubMed ID: 18619927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shorter telomeres in adults with Type 1 diabetes correlate with diabetes duration, but only weakly with vascular function and risk factors.
    Januszewski AS; Sutanto SS; McLennan S; O'Neal DN; Keech AC; Twigg SM; Jenkins AJ
    Diabetes Res Clin Pract; 2016 Jul; 117():4-11. PubMed ID: 27329016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus.
    Streja D; Cressey P; Rabkin SW
    J Diabetes Complications; 2003; 17(3):120-7. PubMed ID: 12738395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin and E-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease(s).
    El-Mesallamy HO; Hamdy NM; Salman TM; Mahmoud S
    Minerva Endocrinol; 2011 Sep; 36(3):163-70. PubMed ID: 22019747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Modifiers of Cystic Fibrosis-Related Diabetes Have Extensive Overlap With Type 2 Diabetes and Related Traits.
    Aksit MA; Pace RG; Vecchio-Pagán B; Ling H; Rommens JM; Boelle PY; Guillot L; Raraigh KS; Pugh E; Zhang P; Strug LJ; Drumm ML; Knowles MR; Cutting GR; Corvol H; Blackman SM
    J Clin Endocrinol Metab; 2020 May; 105(5):1401-15. PubMed ID: 31697830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between pro- and anti-inflammatory cytokines and depressive symptoms in patients with diabetes-potential differences by diabetes type and depression scores.
    Herder C; Schmitt A; Budden F; Reimer A; Kulzer B; Roden M; Haak T; Hermanns N
    Transl Psychiatry; 2018 Mar; 7(11):1. PubMed ID: 29520075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal associations between biomarkers of inflammation and changes in depressive symptoms in patients with type 1 and type 2 diabetes.
    Herder C; Schmitt A; Budden F; Reimer A; Kulzer B; Roden M; Haak T; Hermanns N
    Psychoneuroendocrinology; 2018 May; 91():216-225. PubMed ID: 29525039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased circulating granzyme B in type 2 diabetes patients with low-grade systemic inflammation.
    Cimini FA; D'Eliseo D; Barchetta I; Bertoccini L; Velotti F; Cavallo MG
    Cytokine; 2019 Mar; 115():104-108. PubMed ID: 30473178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbohydrate intake and insulin requirement in children, adolescents and young adults with cystic fibrosis-related diabetes: A multicenter comparison to type 1 diabetes.
    Scheuing N; Thon A; Konrad K; Bauer M; Karsten C; Meissner T; Seufert J; Schönau E; Schöfl C; Woelfle J; Holl RW;
    Clin Nutr; 2015 Aug; 34(4):732-8. PubMed ID: 25245859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microvascular complications in cystic fibrosis-related diabetes.
    Schwarzenberg SJ; Thomas W; Olsen TW; Grover T; Walk D; Milla C; Moran A
    Diabetes Care; 2007 May; 30(5):1056-61. PubMed ID: 17322485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower heart rate variability is associated with higher plasma concentrations of IL-6 in type 1 diabetes.
    González-Clemente JM; Vilardell C; Broch M; Megia A; Caixàs A; Giménez-Palop O; Richart C; Simón I; Martínez-Riquelme A; Arroyo J; Mauricio D; Vendrell J
    Eur J Endocrinol; 2007 Jul; 157(1):31-8. PubMed ID: 17609399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of inflammation and endothelial dysfunction as predictors of pulse pressure and incident hypertension in type 1 diabetes: a 20 year life-course study in an inception cohort.
    Ferreira I; Hovind P; Schalkwijk CG; Parving HH; Stehouwer CDA; Rossing P
    Diabetologia; 2018 Jan; 61(1):231-241. PubMed ID: 29101422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension.
    Tatasciore A; Zimarino M; Renda G; Zurro M; Soccio M; Prontera C; Emdin M; Flacco M; Schillaci G; DE Caterina R
    Hypertens Res; 2008 Dec; 31(12):2137-46. PubMed ID: 19139603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study.
    Schram MT; Chaturvedi N; Schalkwijk C; Giorgino F; Ebeling P; Fuller JH; Stehouwer CD;
    Diabetes Care; 2003 Jul; 26(7):2165-73. PubMed ID: 12832330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.